{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T05:19:34Z","timestamp":1763356774036,"version":"3.45.0"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Ophthalmol."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aimed to characterize the presentation, treatment, and outcomes of preseptal and orbital cellulitis in patients with and without cancer, to help guide management of these infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted at a tertiary care center to identify adults who presented from 2007 to 2022 with orbital and preseptal cellulitis. Patients with cancer were defined as patients actively receiving chemotherapy or in remission but on immunosuppressants at the time of their orbital infection care. Their demographics, presentation, management, and follow-up characteristics were recorded. Management variables included data on antibiotics, antifungals, and systemic steroids administered.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 183 patients presenting with orbital cellulitis, 15 (8.2%) had active cancer while of the 130 patients with preseptal cellulitis, 8 (6.2%) had cancer (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.661). Patients with cancer who were found to have preseptal cellulitis were more likely to have head and neck cancer than those who had orbital cellulitis (50.0 versus 0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.008). In the orbital cellulitis cohort, the management of patients with and without cancer differed in antifungal and corticosteroid therapy. Compared to patients without cancer, patients with cancer received a higher antifungal rate (46.7% versus 10.1%,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.001) and were started on steroids a median of 2 days later (3.0 versus 1.0 day after admission date,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.007). Both cohorts had similar readmission rates (20.0% in cancer and 11.3% in non-cancer cohort,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.397) and eye exam findings at follow-up. Patients with and without cancer in the preseptal cellulitis cohorts were similar in all characteristics assessed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with cancer presenting with orbital cellulitis have a higher rate of antifungal administration and are started on systemic steroids later compared to patients without cancer, although they have similar eye exam outcomes and readmission rates. Patients with cancer are not at an increased risk of preseptal cellulitis and are managed similarly to patients without cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fopht.2025.1676014","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T05:17:14Z","timestamp":1763356634000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Presentation, management, and outcomes of orbital infections in patients with cancer"],"prefix":"10.3389","volume":"5","author":[{"given":"Ava","family":"Niknahad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison B.","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aishah","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heya","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setu","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Al-Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meron","family":"Haile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjana","family":"Srikumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Stemme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akanksha","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin C.","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fasika","family":"Woreta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Rajaii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1001\/jama.2019.18211","article-title":"Periorbital and orbital cellulitis","volume":"323","author":"Baiu","year":"2020","journal-title":"JAMA"},{"key":"B2","article-title":"Periorbital cellulitis","volume-title":"StatPearls","author":"Bae","year":"2023"},{"key":"B3","article-title":"Orbital cellulitis","volume-title":"StatPearls","author":"Danishyar","year":"2023"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/01676830.2021.2002368","article-title":"Microbiological profile and antibiotic susceptibility trends in orbital cellulitis in India: an analysis over 15 years","volume":"41","author":"Joseph","year":"2022","journal-title":"Orbit"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2017.12.001","article-title":"Orbital cellulitis","volume":"63","author":"Tsirouki","year":"2018","journal-title":"Survey Ophthalmology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajem.2023.02.024","article-title":"High risk and low prevalence diseases: Orbital cellulitis","volume":"68","author":"Pelletier","year":"2023","journal-title":"Am J Emergency Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"101044","DOI":"10.1016\/j.disamonth.2020.101044","article-title":"Management of preseptal and orbital cellulitis for the primary care physician","volume":"66","author":"Gordon","year":"2020","journal-title":"Disease-a-Month"},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-62606-2_13","article-title":"Orbital cellulitis in cancer patients","volume-title":"Orbital Cellulitis and Periorbital Infections","author":"Thuro","year":"2018"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i38.13930","article-title":"Acute bacterial infection negatively impacts cancer specific survival of colorectal cancer patients","volume":"20","author":"Atti\u00ea","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"30724","DOI":"10.1038\/s41598-025-16066-6","article-title":"Risk factors for invasive fungal infections in adult patients with hematological Malignancies and\/or stem cell transplant: a systematic review and meta-analysis","volume":"15","author":"Gras","year":"2025","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.10.006","article-title":"Clinical course of preseptal and orbital cellulitis in 50 immunocompromised patients with cancer","volume":"125","author":"Sagiv","year":"2018","journal-title":"Ophthalmology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/QCO.0000000000000632","article-title":"The skin and soft tissue infections in hematological patients","volume":"33","author":"Ungaro","year":"2020","journal-title":"Curr Opin Infect Diseases"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/01676830.2021.1933082","article-title":"Acute inflammatory presentation of orbital metastasis from urothelial carcinoma: a case report","volume":"41","author":"Ghali","year":"2022","journal-title":"Orbit"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/00494755221137628","article-title":"Diagnostic challenge: Diffuse large B-cell lymphoma masquerading as orbital cellulitis","volume":"53","author":"Wen","year":"2023","journal-title":"Trop Doct"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e3180686e63","article-title":"Atypical presentations of pleomorphic adenoma of the lacrimal gland","volume":"23","author":"Vagefi","year":"2007","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_79_22","article-title":"Rhabdomyosarcoma masquerading as orbital cellulitis","volume":"70","author":"Joshi","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01676830.2025.2534564","article-title":"Comparison of management and characteristics of orbital and preseptal cellulitis in adult patients with and without diabetes mellitus: a retrospective cohort study","author":"Niknahad","year":"2025","journal-title":"Orbit"},{"key":"B18","doi-asserted-by":"publisher","first-page":"20585","DOI":"10.1038\/s41598-025-06382-2","article-title":"Clinical characteristics and prognosis of adult orbital cellulitis in a tertiary general hospital","volume":"15","author":"Chen","year":"2025","journal-title":"Sci Rep"}],"container-title":["Frontiers in Ophthalmology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2025.1676014\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T05:17:15Z","timestamp":1763356635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2025.1676014\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":18,"alternative-id":["10.3389\/fopht.2025.1676014"],"URL":"https:\/\/doi.org\/10.3389\/fopht.2025.1676014","relation":{},"ISSN":["2674-0826"],"issn-type":[{"value":"2674-0826","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"article-number":"1676014"}}